PAXLOVID versus TRUVADA
FOR CHRONIC COVID #LONGCOVID #PACS
For costs and side effects
and as months of treatment are required
Win Truvada
containing
Emtricitabine FTC+
Tenofovir Disoproxil FumarateTDF
One could start with Paxlovid and continue with Truvada
FOR CHRONIC COVID #LONGCOVID #PACS
For costs and side effects
and as months of treatment are required
Win Truvada
containing
Emtricitabine FTC+
Tenofovir Disoproxil FumarateTDF
One could start with Paxlovid and continue with Truvada
https://twitter.com/Aguirre1Gustavo/status/1603403224194506752
PROTOCOLS FOR CHRONIC COVID #LONGCOVID
I. INTENSIVE PHASE AGAINST VIRAL LOAD
It includes:
1.FTC/TDF (Truvada). The alternative is to start Paxlovid for 10-25 days and then continue with FTC/TDF
2. IVM or Liposomal Artemisinin or Artesunate
3. ECGC or Nitazoxanide or Ozone 10pass
I. INTENSIVE PHASE AGAINST VIRAL LOAD
It includes:
1.FTC/TDF (Truvada). The alternative is to start Paxlovid for 10-25 days and then continue with FTC/TDF
2. IVM or Liposomal Artemisinin or Artesunate
3. ECGC or Nitazoxanide or Ozone 10pass
The objective of the INTENSIVE PHASE in CHRONIC COVID #LONGCOVID
is to minimize the Viral Load
Lasts 1-2months
Then follows the Maintenance Phase
whose objective is to avoid the Relapse/Reactivation of the infection
The number of drugs is reduced
Lasts 3 to 8months
depending
case
is to minimize the Viral Load
Lasts 1-2months
Then follows the Maintenance Phase
whose objective is to avoid the Relapse/Reactivation of the infection
The number of drugs is reduced
Lasts 3 to 8months
depending
case
FIRST PROTOCOL WITH TRUVADA FOR #LONGCOVID
This 1st Protocol serves as a Therapeutic Test for the diagnosis of VIRAL PERSISTENCE
If the patient presents an improvement of 4 points out of 10
It is POSITIVE for Persistence of Viral Load sensitive to
FTC/TDF:
This 1st Protocol serves as a Therapeutic Test for the diagnosis of VIRAL PERSISTENCE
If the patient presents an improvement of 4 points out of 10
It is POSITIVE for Persistence of Viral Load sensitive to
FTC/TDF:
https://twitter.com/Aguirre1Gustavo/status/1604949389013061632
In the Protocol for #LongCOVID
since days before starting with the Drugs against the Viral Load,
we indicate Antiplatelet/Fibrinolytic
to improve blood flow and
break down #Microclots
that serve the protection and refuge viruses
against immunity and drugs
since days before starting with the Drugs against the Viral Load,
we indicate Antiplatelet/Fibrinolytic
to improve blood flow and
break down #Microclots
that serve the protection and refuge viruses
against immunity and drugs
https://twitter.com/Aguirre1Gustavo/status/1540486641059614721
• • •
Missing some Tweet in this thread? You can try to
force a refresh
